Europe (WHO region) vs South Africa: Cases started on MDR-TB treatment
Europe (WHO region)
40,112
in 2024
South Africa
6,578
in 2024
Europe (WHO region) rank
5th
South Africa rank
6th
Cases started on MDR-TB treatment over time
- Europe (WHO region)
- South Africa
How they compare
Europe (WHO region) currently reports 40,112 against 6,578 in South Africa, a difference of 33,534.
That makes Europe (WHO region)'s figure about 6.1 times South Africa's.
Across all 16 years both countries report, Europe (WHO region) has been ahead every year.
Europe (WHO region) ranks 5th and South Africa ranks 6th of 11 groups.
Europe (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17,169 | 4,143 | 13,026 | Europe (WHO region) |
| 2010s | 45,082 | 9,190 | 35,893 | Europe (WHO region) |
| 2020s | 45,324 | 7,179 | 38,146 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Europe (WHO region) or South Africa?
- Europe (WHO region), at 40,112 against 6,578 in South Africa as of 2024.
- What is the difference in cases started on mdr-tb treatment between Europe (WHO region) and South Africa?
- 33,534, with Europe (WHO region) ahead.
- How many years of comparable data are there for Europe (WHO region) and South Africa?
- 16 years are reported by both, from 2009 to 2024.
- How do Europe (WHO region) and South Africa rank globally for cases started on mdr-tb treatment?
- Europe (WHO region) ranks 5th and South Africa ranks 6th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.